Resistant hypertension

被引:42
作者
Calhoun, DA [1 ]
Zaman, MA [1 ]
Nishizaka, MK [1 ]
机构
[1] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
关键词
D O I
10.1007/s11906-002-0011-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Recent clinical trials suggest that resistant hypertension is increasingly common. In the majority of patients, uncontrolled hypertension is due to persistent elevation of the systolic blood pressure. Older age and obesity are associated with poor blood pressure control. Other contributing factors include severity of the underlying hypertension and renal insufficiency. Poor patient adherence is thought be a common cause of medication resistance. Exogenous substances such as nonsteroidal anti-inflammatory drugs, oral contraceptives, and sympathomimetic agents can interfere with treatment. The prevalence of secondary causes of hypertension increases with age, especially atherosclerotic renal artery stenosis. Recent reports suggest that primary aldosteronism may be the most common secondary cause of Hypertension. It should be considered in all patients with resistant hypertension. Effective treatment of resistant hypertension requires identification and reversal of contributing factors and/or secondary causes of hypertension. Pharmacologic therapy should utilize combination therapy, including a long-acting diuretic.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 51 条
[1]  
Aguilera MT, 1999, HYPERTENSION, V33, P653
[2]   THE EFFECT OF AGE ON PREVALENCE OF SECONDARY FORMS OF HYPERTENSION IN 4429 CONSECUTIVELY REFERRED PATIENTS [J].
ANDERSON, GH ;
BLAKEMAN, N ;
STREETEN, DHP .
JOURNAL OF HYPERTENSION, 1994, 12 (05) :609-615
[3]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[4]   RELATION OF WEIGHT CHANGE TO CHANGES IN ATHEROGENIC TRAITS - FRAMINGHAM STUDY [J].
ASHLEY, FW ;
KANNEL, WB .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (03) :103-114
[5]   Baseline characteristics and early blood pressure control in the CONVINCE trial [J].
Black, HR ;
Elliott, WJ ;
Neaton, JD ;
Grandits, G ;
Grambsch, P ;
Grimm, RH ;
Hansson, L ;
Lacoucière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
White, WB ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Fakouhi, TD ;
Anders, RJ .
HYPERTENSION, 2001, 37 (01) :12-18
[6]   RENAL-ARTERY ANGIOPLASTY - TECHNICAL RESULTS AND CLINICAL OUTCOME IN 320 PATIENTS [J].
BONELLI, FS ;
MCKUSICK, MA ;
TEXTOR, SC ;
KOS, PB ;
STANSON, AW ;
JOHNSON, CM ;
SHEEDY, PF ;
WELCH, TJ ;
SCHIRGER, A .
MAYO CLINIC PROCEEDINGS, 1995, 70 (11) :1041-1052
[7]   Renal effects of COX-2-selective inhibitors [J].
Brater, DC ;
Harris, C ;
Redfern, JS ;
Gertz, BJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) :1-15
[8]   PERCUTANEOUS TRANS-LUMINAL RENAL ANGIOPLASTY IN MANAGEMENT OF ATHEROSCLEROTIC RENOVASCULAR HYPERTENSION - RESULTS IN 100 PATIENTS [J].
CANZANELLO, VJ ;
MILLAN, VG ;
SPIEGEL, JE ;
PONCE, SP ;
KOPELMAN, RI ;
MADIAS, NE .
HYPERTENSION, 1989, 13 (02) :163-172
[9]  
CUSHMAN WC, 1998, AM J HYPERTENS, V11, pA17
[10]   Effect of continuous positive airway pressure on blood pressure - A placebo trial [J].
Dimsdale, JE ;
Loredo, JS ;
Profant, J .
HYPERTENSION, 2000, 35 (01) :144-147